Paul Industries delivers sanitary process piping for pharmaceutical manufacturers as a single-source supplier and installer. We design, fabricate, install, passivate, and validate sanitary and high-purity process piping – the orbital-welded, ASME BPE stainless systems that carry product, WFI, clean steam, and process gases through a regulated plant – built to the standards your process and your auditors require.
What pharmaceutical manufacturers need from sanitary process piping
Pharmaceutical manufacturing lives and dies by cGMP compliance – FDA 21 CFR Parts 210/211, validated systems, and audit-ready documentation. Whether the process is oral solid dose, sterile injectables, or API synthesis, the utilities behind it (process water, clean steam, sanitary piping, CIP/SIP) have to be designed, installed, and documented to survive an FDA inspection.
For this work, that means cGMP (21 CFR 210/211) compliance, validated IQ/OQ/PQ turnover, USP-monograph water quality, and fully documented, traceable installations – not as an afterthought, but engineered in from the first drawing.
What we deliver
- ASME BPE-compliant 316L stainless, orbital-welded for a fully documented, crevice-free flow path
- Automated orbital GTAW welding with weld maps, weld logs, and borescope/coupon records for validation
- Slope-and-drainability layout so lines self-drain for CIP/SIP and sterility
- Electropolished and passivated interior surfaces to spec (typically 15-20 Ra microinch)
- Full material traceability (MTRs) and turnover packages ready for FDA/cGMP audit
One accountable partner
Most pharmaceutical projects get split between an equipment supplier and an install contractor – and the validation burden falls in the gap between them. Paul Industries closes that gap by self-performing the whole scope, from supply through documented turnover.
Related: Sanitary Process Piping services · Pharmaceutical Manufacturers solutions · Request a quote
Frequently asked questions
What is sanitary process piping for pharmaceutical manufacturing?
It is hygienic stainless piping that conveys purified water, WFI, clean steam, buffers, and drug product through smooth, drainable, crevice-free flow paths built to ASME BPE and cGMP. The design prioritizes cleanability, documentation, and contamination control. Paul Industries designs, fabricates, installs, and validates these systems.
What standards apply to pharmaceutical process piping?
ASME BPE governs hygienic design, finish, and joining; cGMP sets FDA expectations; USP <643> and <645> cover water quality (TOC and conductivity); USP <1231> covers water for pharmaceutical purposes; ASTM A967/A380 covers passivation. Paul Industries builds and documents pharma piping to these standards.
Why is documentation so important in pharmaceutical piping?
FDA-regulated manufacturers must prove their systems are built and cleaned to control contamination. Weld logs, material test reports, slope and pressure tests, passivation certificates, and validation records create an auditable trail. Without complete documentation, a technically sound system can still fail inspection.
How does pharmaceutical piping support cleaning validation?
By making the surfaces reachable and the geometry defensible, which is what cleaning validation ultimately tests. Continuous slope so every run drains, dead legs minimized so flow scours every branch, zero-static valves at points of use, and an internal finish smooth enough that residue does not key into it. Where the pipework fails on those, no cycle development will rescue it: worst-case sampling locations will be exactly the places the CIP solution cannot reach at velocity.
What surface finish do pharmaceutical product-contact lines need?
Product-contact surfaces typically target around Ra 20 µin mechanically polished or roughly Ra 15 µin electropolished per the URS, to resist residue, biofilm, and rouge. Hot WFI and clean-steam lines often specify electropolish. Paul Industries builds to the specified finish and records Ra at turnover.
How do you eliminate dead legs in pharmaceutical piping?
Dead legs are minimized by keeping branch stubs short (commonly within ASME BPE’s L/D guidance), using zero-static or diaphragm valves at points of use, and sloping lines to drain. Eliminating hold-up volume prevents stagnation where bioburden and endotoxin could accumulate between cleanings.
What is passivation and why do pharmaceutical systems need it?
Passivation removes surface iron and restores a chromium-rich passive oxide layer after fabrication, per ASTM A967/A380 using citric or nitric processes. It improves corrosion resistance and delays rouge in high-purity water and clean steam. Passivation certificates are part of the pharma turnover package.
How are pharmaceutical piping systems validated?
Validation runs IQ to verify installation and documentation, OQ to confirm operating parameters such as slope, flow, and pressure, and PQ to demonstrate repeatable cleaning and quality performance. Paul Industries performs commissioning and IQ/OQ/PQ, tying results back to weld and passivation records.
Why is WFI piping treated differently from other lines?
WFI must stay endotoxin- and microbe-free, so its distribution loop is usually hot-circulated, fully drainable, electropolished, and dead-leg-free, often with continuous flow to prevent stagnation. The finish and passivation are tighter than for ambient utility lines because rouge and biofilm directly threaten water quality.
What causes pharmaceutical piping to fail an FDA inspection?
Almost never the welds themselves, and usually the records. The recurring findings are a weld map that does not reconcile with the passivation certificate, normally because passivation preceded the final tie-ins so the connecting joints were never covered; material certificates that stop at the purchase order so a specific heat cannot be traced to a specific joint; two parallel weld logs produced by different contractors; and nonconformances raised with no documented disposition. Modifications made without change control are the other.
Do you handle clean steam and SIP piping?
Yes, and clean steam piping is where the mechanical detail decides whether cycles pass. Every line must fall continuously to a trap point, because trapped condensate physically blocks steam from reaching the surface it is meant to sterilize. Trap selection and placement are design items rather than details, and sanitary traps rather than standard industrial units are required. Sample points need positioning so EN 285 testing can actually be performed rather than approximated.
How much does pharmaceutical process piping cost?
Cost depends on line count and size, material and finish, valve and instrument selection, CIP/SIP integration, and validation scope, so a blanket figure is misleading. Electropolish, extensive orbital welding, and full IQ/OQ/PQ raise cost. Paul Industries scopes to your URS. Call 201-450-8280.
How long does a pharmaceutical piping project take?
A single tie-in with a short run is a few days of field work inside an available window, though line clearing, lock-out and hot work permitting in a running plant often take longer than the welding. A process area fit-out is typically three to eight weeks including prefabrication. A full compendial loop is a multi-month program. The tail that governs the finish date is not welding but requalification: passivation, sanitization and sampling run on laboratory incubation rather than crew size.
Can Paul Industries deliver pharmaceutical piping nationwide?
Yes, nationwide from Kilmarnock, Virginia, as planned mobilizations with dates confirmed at quotation. We do not run regional branches. A large share of the weld volume is prefabricated as shop spools before crews travel, which costs roughly 55 to 120 dollars per weld against 100 to 200 in the field and carries a lower reject rate. For genuine same-hour emergency attendance a contractor with local presence will serve you better, and we say so at the first call.
Why choose a single-source contractor for pharmaceutical piping?
Because passivation sequencing and documentation ownership are the two things that break on split scopes, and both are invisible until qualification. Passivation must follow the final tie-ins, since welding leaves a chromium-depleted zone; when a separate firm treats the system before those joints are made, the connecting welds are left untreated and outside every certificate. And when welding and passivation sit with different parties, the weld map and the certificate frequently do not reconcile. One contract removes both.
How do I start a pharmaceutical piping project?
Send isometrics or a process and instrumentation diagram, the fluid and its service conditions, the ASME B31.3 fluid service category and surface finish you believe apply, whether this is a tie-in to an operating system or new work, your shutdown window, and the documentation package required at turnover. If your organization runs supplier qualification before award, start it in parallel. If the specification exceeds what the process needs, we will say so before pricing it.
What pharmaceutical requirements do you build to?
ASME BPE for bioprocessing pipework, including SF4 electropolished product contact surfaces where compendial water or drug product contact applies, drainability and the weld documentation and material traceability the standard expects. ASME B31.3 governs pressure design and its fluid service categories set examination scope. Welders and procedures are qualified to ASME Section IX. Passivation follows ASTM A967. The quality framework is 21 CFR 211, with EU GMP Annex 1 for sterile product supplied into Europe.
Get a single-source quote
Paul Industries designs, fabricates, installs, passivates, and validates – one accountable partner instead of a vendor plus a contractor plus a validation firm. Tell us about your project and we will scope it.
What does pharmaceutical sanitary process piping have to meet?
| Requirement | What it means |
|---|---|
| Design standard | ASME BPE for hygienic design; ASME B31.3 for the pressure boundary |
| Material | ASTM A270 sanitary tube, 316L, heat-number traceable |
| Surface finish | Specified Ra against an ASME BPE designation; electropolished where required |
| Joining | Orbital welded wherever geometry allows, with a recorded schedule per weld |
| Dead legs | L/D of 2:1 or less measured inner-wall to sealing face |
| Drainability | Continuous fall to a low point; no sagging runs between supports |
| Passivation | ASTM A967 after installation, with ASTM A380 pre-cleaning and verification |
| Turnover | Weld map, logs, coupons, MTRs, slope records, passivation results, indexed to IQ |
Do you handle validation, or just installation?
Both. For pharmaceutical piping the qualification scope is set by risk rather than by how much pipe was touched, and that is a judgement best made by the party that did the work. A small tie-in on a compendial loop can require sampling across the entire loop, because the change affects the qualified state of everything downstream of it. Paul Industries performs the commissioning and IQ, OQ and PQ tied to the weld log, passivation certificate and slope verification, and assesses the requalification extent as part of the change rather than after it. Installation without that assessment leaves the plant to discover the scope during its own review.
Can you take a project from design through startup?
Yes. On pharmaceutical piping the reason to hold design through startup together is that most of this work is a tie-in to a plant still making product, where the weld takes a day and the requalification takes weeks. Under a split scope the welding contractor finishes on schedule and the requalification becomes somebody else’s discovery. One contract means the requalification extent is established at design, the outage is planned around it rather than around the mechanical work, and the documentation that supports it is captured as the welds are made rather than reconstructed afterwards.